Nighat Yasmin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Escherichia Coli

Silver Nanoparticles

Top Venues

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Aamir Jamal Gondal, Nakhshab Choudhry, Ammara Niaz, Nighat Yasmin
Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant Pseudomonas aeruginosa Clinical Strains: A Challenge for Tertiary Care Hospitals. Antibiotics (Basel, Switzerland) 13 (2) (2024)
Aamir Jamal Gondal, Nakhshab Choudhry, Ammara Niaz, Nighat Yasmin
Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant Pseudomonas aeruginosa Clinical Strains: A Challenge for Tertiary Care Hospitals. Antibiotics (Basel, Switzerland) 13 (2) (2024)
Aamir Jamal Gondal, Nakhshab Choudhry, Ammara Niaz, Nighat Yasmin
Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant Pseudomonas aeruginosa Clinical Strains: A Challenge for Tertiary Care Hospitals. Antibiotics (Basel, Switzerland) 13 (2) (2024)
Zainab Rizvi, Nakhshab Choudhry, Aamir Jamal Gondal, Nighat Yasmin
Association of Surfactant Protein D Single Nucleotide Polymorphisms rs721917, rs2243639, rs3088308 with Recurrent Aphthous Stomatitis in Pakistani Population. Genes 14 (5) (2023)
Aamir Jamal Gondal, Nakhshab Choudhry, Hina Bukhari, Zainab Rizvi, Shah Jahan, Nighat Yasmin
Estimation, Evaluation and Characterization of Carbapenem Resistance Burden from a Tertiary Care Hospital, Pakistan. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Aamir Jamal Gondal, Nakhshab Choudhry, Hina Bukhari, Zainab Rizvi, Shah Jahan, Nighat Yasmin
Estimation, Evaluation and Characterization of Carbapenem Resistance Burden from a Tertiary Care Hospital, Pakistan. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Aamir Jamal Gondal, Nakhshab Choudhry, Hina Bukhari, Zainab Rizvi, Nighat Yasmin
Characterization of Genomic Diversity among Carbapenem-Resistant Escherichia coli Clinical Isolates and Antibacterial Efficacy of Silver Nanoparticles from Pakistan. Microorganisms 10 (11) (2022)